Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study

2013492 citationsJournal Articlebronze Open Access

Authors

Atsushi Ohtsu

Jaffer A. Ajani

Yu-Xian Bai

Yung‐Jue Bang

Hyun Cheol Chung · Yonsei University

Abstract

Compared with BSC, everolimus did not significantly improve overall survival for advanced gastric cancer that progressed after one or two lines of previous systemic chemotherapy. The safety profile observed for everolimus was consistent with that observed for everolimus in other cancers.

Topics & Keywords

Gastric Cancer Management and Outcomes Cholangiocarcinoma and Gallbladder Cancer Studies Metastasis and carcinoma case studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 31, Issue 31, pp. 3935-3943

DOI: 10.1200/jco.2012.48.3552

Field-Weighted Citation Impact: 42.65